Zai Lab Limited (ZLAB) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Zai Lab Limited (ZLAB) Bundle
Gain insights into your Zai Lab Limited (ZLAB) valuation analysis with our powerful DCF Calculator! Preloaded with real ZLAB data, this Excel template enables you to adjust forecasts and assumptions to determine Zai Lab Limited's intrinsic value accurately.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.0 | 49.0 | 144.3 | 215.0 | 266.7 | 448.8 | 755.1 | 1,270.6 | 2,137.9 | 3,597.2 |
| Revenue Growth, % | 0 | 277.04 | 194.77 | 49.01 | 24.03 | 68.26 | 68.26 | 68.26 | 68.26 | 68.26 |
| EBITDA | -187.5 | -258.7 | -690.8 | -396.1 | -366.6 | -448.8 | -755.1 | -1,270.6 | -2,137.9 | -3,597.2 |
| EBITDA, % | -1444.14 | -528.32 | -478.69 | -184.21 | -137.44 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 6.5 | 8.9 | 12.6 | 16.6 | 9.0 | 79.2 | 133.2 | 224.2 | 377.2 | 634.8 |
| Depreciation, % | 50.12 | 18.28 | 8.74 | 7.71 | 3.39 | 17.65 | 17.65 | 17.65 | 17.65 | 17.65 |
| EBIT | -194.0 | -267.6 | -703.4 | -412.7 | -375.6 | -448.8 | -755.1 | -1,270.6 | -2,137.9 | -3,597.2 |
| EBIT, % | -1494.26 | -546.6 | -487.43 | -191.92 | -140.82 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 275.9 | 1,186.8 | 1,409.1 | 1,008.5 | 806.5 | 448.8 | 755.1 | 1,270.6 | 2,137.9 | 3,597.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3.8 | 5.2 | 54.8 | 48.6 | 65.3 | 112.0 | 188.5 | 317.2 | 533.6 | 897.9 |
| Account Receivables, % | 29.2 | 10.55 | 37.98 | 22.59 | 24.5 | 24.96 | 24.96 | 24.96 | 24.96 | 24.96 |
| Inventories | 6.0 | 13.1 | 19.0 | 31.6 | 44.8 | 105.7 | 177.8 | 299.2 | 503.4 | 847.1 |
| Inventories, % | 46.25 | 26.85 | 13.13 | 14.7 | 16.81 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 |
| Accounts Payable | 22.7 | 62.6 | 126.2 | 66.0 | 113.0 | 323.5 | 544.4 | 916.0 | 1,541.3 | 2,593.4 |
| Accounts Payable, % | 174.51 | 127.95 | 87.42 | 30.68 | 42.36 | 72.09 | 72.09 | 72.09 | 72.09 | 72.09 |
| Capital Expenditure | -15.2 | -10.7 | -18.9 | -25.0 | -8.5 | -134.4 | -226.1 | -380.5 | -640.2 | -1,077.2 |
| Capital Expenditure, % | -117.38 | -21.79 | -13.13 | -11.62 | -3.18 | -29.94 | -29.94 | -29.94 | -29.94 | -29.94 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -183.1 | -298.0 | -692.4 | -449.0 | -375.6 | -442.3 | -744.3 | -1,252.3 | -2,107.1 | -3,545.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -179.0 | -268.2 | -690.7 | -524.0 | -358.0 | -394.5 | -764.9 | -1,287.0 | -2,165.5 | -3,643.7 |
| WACC, % | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 | 9.31 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -5,837.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -3,717 | |||||||||
| Terminal Value | -50,836 | |||||||||
| Present Terminal Value | -32,573 | |||||||||
| Enterprise Value | -38,410 | |||||||||
| Net Debt | -775 | |||||||||
| Equity Value | -37,635 | |||||||||
| Diluted Shares Outstanding, MM | 97 | |||||||||
| Equity Value Per Share | -389.44 |
What You Will Receive
- Comprehensive Financial Model: Zai Lab Limited’s actual data provides a reliable DCF valuation.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Instant updates allow you to view results as you make adjustments.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
- Adaptable and Reusable: Designed for versatility, enabling ongoing use for in-depth forecasting.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue projections, operating margins, and R&D expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, net present value, and additional financial metrics.
- High-Precision Accuracy: Leverages Zai Lab's (ZLAB) actual financial data for dependable valuation results.
- Effortless Scenario Testing: Explore various assumptions and analyze results with ease.
- Efficiency Booster: Streamline your valuation process without the hassle of constructing intricate models from the ground up.
How It Works
- Download: Get the pre-prepared Excel file containing Zai Lab Limited's (ZLAB) financial data.
- Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and instantly compare the results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose This Calculator for Zai Lab Limited (ZLAB)?
- Tailored for Experts: A sophisticated tool designed for analysts, investors, and financial advisors.
- Accurate Data: Zai Lab's historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Comprehensive Outputs: Instantly calculates intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment related to Zai Lab Limited (ZLAB).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations regarding Zai Lab Limited (ZLAB).
- Consultants and Advisors: Deliver precise valuation insights to clients considering investments in Zai Lab Limited (ZLAB).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling with a focus on Zai Lab Limited (ZLAB).
- Biotech Enthusiasts: Gain insights into how biotech companies like Zai Lab Limited (ZLAB) are assessed in the financial markets.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Zai Lab Limited (ZLAB) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Zai Lab Limited (ZLAB).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.